Nanalysis Scientific Corp. (TSXV:NSCI)
Canada · Delayed Price · Currency is CAD | Market Cap | 21.46M -35.7% |
| Revenue (ttm) | 40.13M -11.8% |
| Net Income | -5.66M |
| EPS | -0.05 |
| Shares Out | 138.45M |
| PE Ratio | n/a |
| Forward PE | 17.22 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 79,311 |
| Average Volume | 102,410 |
| Open | 0.1450 |
| Previous Close | 0.1350 |
| Day's Range | 0.1450 - 0.1550 |
| 52-Week Range | 0.1100 - 0.3400 |
| Beta | 0.12 |
| RSI | 57.15 |
| Earnings Date | Apr 8, 2026 |
About Nanalysis Scientific
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa... [Read more]
Financial Performance
In 2025, Nanalysis Scientific's revenue was 40.13 million, a decrease of -11.79% compared to the previous year's 45.50 million. Losses were -5.66 million, -58.44% less than in 2024.
Financial StatementsNews
Nanalysis Scientific Corp (NSCIF) Q4 2025 Earnings Call Highlights: Navigating Challenges and ...
Nanalysis Scientific Corp (NSCIF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Focusing on Proprietary Growth
Q4 2025 Nanalysis Scientific Corp Earnings Call Transcript
Q4 2025 Nanalysis Scientific Corp Earnings Call Transcript
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand CALGARY, AB, April 8, 2026 /PRNewswire/ - Nanalys...
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand CALGARY, AB , April 8, 2026 /CNW/ - Nanalysis Sci...
Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call
Hosting Call at 10am ET on Thursday, April 9th CALGARY, AB, April 2, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR instruments and imag...
Nanalysis Announces Grant of Options and Restricted Share Units
CALGARY, AB, March 4, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI) (FRA: 1N1) announces the Company's Board of Directors has granted 1,210,000 restricted...
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
CALGARY, AB, Jan. 26, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") ( TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1) is pleased to announce, further to its December 8, 2025 and...
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
CALGARY, AB , Dec. 23, 2025 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") ( TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1) is pleased to announce that it has closed the first tranch...
Nanalysis Announces $2.5 Million Private Placement
CALGARY, AB , Dec. 8, 2025 /PRNewswire/ -Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it intends to complete a non-brokere...
Nanalysis Announces Third Quarter 2025 Results
CALGARY, AB , Nov. 24, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and ...
Nanalysis Announces Third Quarter 2025 Conference Call
Hosting Call at 4:15 pm ET on Monday, November 24th CALGARY, AB , Nov. 18, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable N...
Nanalysis Announces Change of Management
Not for distribution to U.S. newswire services or dissemination in the United States CALGARY, AB , Nov. 14, 2025 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI) (...
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
CALGARY, AB , Oct. 7, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magne...
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
CALGARY, AB , Sept. 3, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magn...
Nanalysis Announces Second Quarter 2025 Results
CALGARY, AB , Aug. 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial a...
Nanalysis Announces Second Quarter 2025 Conference Call
Hosting Call at 5:00 pm ET on Thursday, August 28th European Q&A Session on Friday, August 29th at 8:30am ET CALGARY, AB , Aug. 21, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV:...
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)
CALGARY, AB , July 9, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and res...
Nanalysis Announces First Quarter 2025 Results
Delivers Another Quarter of Positive Adjusted EBITDA & Operating Cash Flow CALGARY, AB , May 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), ...
Nanalysis Announces First Quarter 2025 Conference Call
Hosting Call at 5:00 pm ET on Wednesday, May 28th European Q&A Session on Thursday, May 29th at 8:30am ET CALGARY, AB , May 15, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NS...
Nanalysis Announces Fourth Quarter and Full Year 2024 Results
Company Achieves Record Quarterly Revenue of $12.3MM and Adjusted EBITDA of $1.8MM Reports Record Annual Revenue of $45MM and Adjusted EBITDA of $2.8MM CALGARY, AB , April 24, 2025 /PRNewswire/ - Nana...
Nanalysis Announces Fourth Quarter and Full Year 2024 Conference Call
Hosting Call at 5:00 pm ET on Thursday, April 24th European Q&A Session on Friday, April 25th at 8:30am ET CALGARY, AB , April 17, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: ...
Nanalysis Announces Release of Automation Software
Provides Ease of Use and Reduces Expertise Required to Collect Data CALGARY, AB , March 18, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader...
Nanalysis Announces Next Generation 60MHz Benchtop NMR Spectrometer
Debuting at Pittcon Conference and Expo in Boston, MA March 1-5th CALGARY, AB , March 5, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in...
Nanalysis Provides Fourth Quarter Preview (Unaudited)
Achieves Record Quarterly Adjusted EBITDA of at least $1 Million & Positive Free Cash-Flow CALGARY, AB , Feb. 27, 2025 /PRNewswire/ - Nanalysis Scientific Corp. "the Company", (TSXV: NSCI), (OTCQX: NS...
Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control
CALGARY, AB , Dec. 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and re...